T282M (p.Thr282Met) variant of AGTR1 (Type-1 angiotensin II receptor)

T282M (p.Thr282Met) in AGTR1 (Type-1 angiotensin II receptor) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Renal tubular dysgenesis. The available variant effect predictions contribute to a CATVariant prioritization score of 0.56 / 1. The record also includes population frequency data, published literature, and structural context.

T282M (p.Thr282Met) variant details